FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-479 | 76154-479-01 | Vasopressin | 1 [USP'U]/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-466 | 76154-466-15 | Epinephrine | 16 ug/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-470 | 76154-470-15 | Epinephrine | 32 ug/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-031 | 71591-031-01 | Fluconazole | 300 mg | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-030 | 71591-030-01 | Fluconazole | 75 mg | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-032 | 71591-032-01 | Fluconazole | 400 mg | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-033 | 71591-033-01 | Fluconazole | 100 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-033 | 71591-033-02 | Fluconazole | 100 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-037 | 71591-037-01 | Gabapentin | 150 mg | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-035 | 71591-035-01 | Gabapentin | 25 mg | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-036 | 71591-036-01 | Gabapentin | 50 mg | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-040 | 71591-040-01 | Gabapentin | 100 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-038 | 71591-038-01 | Gabapentin | 50 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-039 | 71591-039-01 | Gabapentin | 75 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | Glycopyrrolate | .4 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-500 | 71591-500-50 | Ascorbic Acid | 500 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | Ketoconazole; Amikacin Sulfate; Triamcinolone Acetonide | 1 g/100 mL; .67 g/100 mL; .1 g/100 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-004 | 71591-004-06 | Ketoconazole; Enrofloxacin; Triamcinolone Acetonide | 1 g/100 mL; .23 g/100 mL; .1 g/100 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | Ketoconazole; Gentamicin Sulfate; Triamcinolone Acetonide | 1 g/100 mL; .67 g/100 mL; .1 g/100 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-021 | 71591-021-01 | Lidocaine; Tetracaine; Benzocaine | 6 g/100 g; 4 g/100 g; 20 g/100 g | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-042 | 71591-042-50 | Meloxicam | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-020 | 71591-020-01 | Metronidazole | 150 mg | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-017 | 71591-017-01 | Metronidazole Benzoate | 50 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-008 | 71591-008-01 | Metronidazole Benzoate | 100 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | Metronidazole Benzoate | 80 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Atlas Pharmaceuticals, LLC(057234359)" | Metronidazole Benzoate | 80 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-016 | 71591-016-01 | Metronidazole Benzoate | 100 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | Metronidazole Benzoate | 160 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Atlas Pharmaceuticals, LLC(057234359)" | Metronidazole Benzoate | 160 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-009 | 71591-009-01 | Metronidazole Benzoate | 50 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-018 | 71591-018-01 | Metronidazole Benzoate | 80 mg | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-019 | 71591-019-01 | Metronidazole Benzoate | 40 mg | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-043 | 71591-043-60 | Ponazuril | 90 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-045 | 71591-045-30 | Ponazuril | 227 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-046 | 71591-046-01 | Praziquantel; Pyrantel Pamoate; Oxantel Pamoate | 22.7 mg; 65.376 mg; 252 mg | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-047 | 71591-047-01 | Prednisolone | 5 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-048 | 71591-048-01 | Prednisolone | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-052 | 71591-052-01 | Secnidazole | 140 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-900 | 71591-900-30 | Sodium Chloride | 9 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-006 | 71591-006-15 | Buprenorphine Hydrochloride | .6 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-011 | 71591-011-30 | Buprenorphine Hydrochloride | .6 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-011 | 71591-011-60 | Buprenorphine Hydrochloride | .6 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-003 | 71591-003-60 | Buprenorphine Hydrochloride | .3 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-003 | 71591-003-30 | Buprenorphine Hydrochloride | .3 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-015 | 71591-015-30 | Buprenorphine Hydrochloride | .15 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-027 | 71591-027-01 | Doxycycline | 100 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-026 | 71591-026-01 | Doxycycline Anhydrous | 50 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-023 | 71591-023-01 | Doxycycline Hyclate | 150 mg | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-022 | 71591-022-01 | Doxycycline Hyclate | 300 mg | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-024 | 71591-024-01 | Doxycycline Hyclate | 125 mg | 2019-1 | valid | 2026-11-14 |